In our recent study comparing IF and qPCR for the detection of CTCs in ovarian cancer patients, we achieved just moderate agreement by using a panel of antibodies for IF (including EpCAM) and cyclophilin C transcripts for the qPCR-based detection of CTCs [28]. This evidence concerns the gene PPIC and ovarian carcinoma.